ALEXANDRIA, Va., March 19 -- United States Patent no. 12,252,543, issued on March 18, was assigned to INNATE PHARMA (Marseilles, France).
"Multispecific NK engager protein" was invented by Laurent Gauthier (Marseilles, France), Nadia Anceriz (Aubagne, France), Ariane Morel (Marseilles, France) and Benjamin Rossi (Marseilles, France).
According to the abstract* released by the U.S. Patent & Trademark Office: "Multispecific proteins that bind and specifically redirect NK cells to lyse a target cell of interest are provided without non-specific activation of NK cells in absence of target cells. The proteins have utility in the treatment of disease, notably cancer or infectious disease."
The patent was filed on Oct. 29, 2018, under Applicati...